Menu
Currency
GWAS Study

Systematic assessment of COVID-19 host genetics using whole genome sequencing data.

Schmidt A, Casadei N, Brand F et al.

39715278 PubMed ID
GWAS Study Type
1017 Participants
37 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SA
Schmidt A
CN
Casadei N
BF
Brand F
DG
Demidov G
VE
Vojgani E
AA
Abolhassani A
AR
Aldisi R
BG
Butler-Laporte G
AT
Alawathurage TM
AM
Augustin M
BR
Bals R
BC
Bellinghausen C
BM
Berger MM
BM
Bitzer M
BC
Bode C
BJ
Boos J
BT
Brenner T
CO
Cornely OA
ET
Eggermann T
EJ
Erber J
FT
Feldt T
FC
Fuchsberger C
GJ
Gagneur J
GS
Göpel S
HT
Haack T
HH
Häberle H
HF
Hanses F
HJ
Heggemann J
HU
Hehr U
HJ
Hellmuth JC
HC
Herr C
HA
Hinney A
HP
Hoffmann P
IT
Illig T
JB
Jensen BO
KV
Keitel V
KS
Kim-Hellmuth S
KP
Koehler P
KI
Kurth I
LA
Lanz AL
LE
Latz E
LC
Lehmann C
LT
Luedde T
MC
Maj C
MM
Mian M
MA
Miller A
MM
Muenchhoff M
PI
Pink I
PU
Protzer U
RH
Rohn H
RJ
Rybniker J
SF
Scaggiante F
SA
Schaffeldt A
SC
Scherer C
SM
Schieck M
SS
Schmidt SV
SP
Schommers P
SC
Spinner CD
VM
Vehreschild MJGT
VT
Velavan TP
VS
Volland S
WS
Wilfling S
WC
Winter C
RJ
Richards JB
HA
Heimbach A
BK
Becker K
OS
Ossowski S
SJ
Schultze JL
NP
Nürnberg P
NM
Nöthen MM
MS
Motameny S
NM
Nothnagel M
RO
Riess O
SE
Schulte EC
LK
Ludwig KU
Chapter II

Abstract

Summary of the research findings

Courses of SARS-CoV-2 infections are highly variable, ranging from asymptomatic to lethal COVID-19. Though research has shown that host genetic factors contribute to this variability, cohort-based joint analyses of variants from the entire allelic spectrum in individuals with confirmed SARS-CoV-2 infections are still lacking. Here, we present the results of whole genome sequencing in 1,220 mainly vaccine-naïve individuals with confirmed SARS-CoV-2 infection, including 827 hospitalized COVID-19 cases. We observed the presence of autosomal-recessive or likely compound heterozygous monogenic disorders in six individuals, all of which were hospitalized and significantly younger than the rest of the cohort. We did not observe any suggestive causal variants in or around the established risk gene TLR7. Burden testing in the largest population subgroup (i.e., Europeans) suggested nominal enrichments of rare variants in coding and non-coding regions of interferon immune response genes in the overall analysis and male subgroup. Case-control analyses of more common variants confirmed associations with previously reported risk loci, with the key locus at 3p21 reaching genome-wide significance. Polygenic scores accurately captured risk in an age-dependent manner. By enabling joint analyses of different types of variation across the entire frequency spectrum, this data will continue to contribute to the elucidation of COVID-19 etiology.

655 European ancestry cases, 362 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1017
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Italy, Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.